Compare TLRY & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLRY | SSII |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | India |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.6M | 752.2M |
| IPO Year | 2018 | N/A |
| Metric | TLRY | SSII |
|---|---|---|
| Price | $7.47 | $4.20 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $103.33 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 146.1K |
| Earning Date | 01-08-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $837,323,000.00 | $36,066,457.00 |
| Revenue This Year | $7.39 | N/A |
| Revenue Next Year | $4.76 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.98 | ★ 158.36 |
| 52 Week Low | $3.51 | $3.02 |
| 52 Week High | $23.20 | $22.42 |
| Indicator | TLRY | SSII |
|---|---|---|
| Relative Strength Index (RSI) | 43.17 | 44.05 |
| Support Level | $7.41 | $3.31 |
| Resistance Level | $8.31 | $5.00 |
| Average True Range (ATR) | 0.42 | 0.66 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 32.03 | 43.00 |
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.